Neurocrine Biosciences, Inc. (NBIX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Neurocrine Biosciences, Inc. (NBIX)
Go deeper and ask any question about NBIX
Company Performance
Current Price
as of Sep 17, 2024$122.31
P/E Ratio
36.95
Market Cap
$12.35B
Description
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerNBIX
- Price$122.31+0.05%
Trading Information
- Market Cap$12.35B
- Float97.82%
- Average Daily Volume (1m)1,128,087
- Average Daily Volume (3m)925,194
- EPS$3.43
Company
- Revenue$2.12B
- Rev Growth (1yr)30.37%
- Net Income$65.00M
- Gross Margin97.36%
- EBITDA Margin26.30%
- EBITDA$155.20M
- EV$13.56B
- EV/Revenue6.40
- P/E36.95
- P/S6.00
Documents
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia